Cargando…
Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
BACKGROUND: Primary Sjögren’s syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to inves...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283727/ https://www.ncbi.nlm.nih.gov/pubmed/35844507 http://dx.doi.org/10.3389/fimmu.2022.904682 |
_version_ | 1784747389792288768 |
---|---|
author | Deng, Jian Liu, Mengsi Xiao, Ruoyi Wang, Jin Liao, Xibei Ye, Zhen Sun, Zhen |
author_facet | Deng, Jian Liu, Mengsi Xiao, Ruoyi Wang, Jin Liao, Xibei Ye, Zhen Sun, Zhen |
author_sort | Deng, Jian |
collection | PubMed |
description | BACKGROUND: Primary Sjögren’s syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to investigate the risk, incidence, and mortality of breast cancer in patients with pSS. METHODS: We systematically searched Embase, PubMed, and Web of Science on January 31, 2022 to identify the study that assessed risk, incidence, or mortality of breast cancer in pSS. The fixed or random-effects models were applied to pool the effect estimates based on heterogeneity measured by Cochran’s Q-test and Higgins’ I(2). RESULTS: Ten studies involving 725,805 participants and 64,836 pSS patients were included in our analysis. The pooled result showed that, overall, pSS was not associated with the risk (SIR=0.92, 95%CI: 0.66-1.29, P=0.646) and mortality (HR = 0.78, 95%CI: 0.26-2.34, P = 0.664) of breast cancer; however, when stratified by geographic region, we found that patients with pSS in Asian countries (SIR=1.32, 95%CI: 1.10-1.58, P=0.003) and Argentina (SIR=3.76, 95%CI: 1.04-9.45, P=0.019) had an elevated risk of breast cancer, while pSS in Europe was associated with a reduced risk (SIR=0.61, 95%CI: 0.51-0.73, P<0.001). The pooled result from 28,635 female pSS patients indicated that the incidence of breast cancer was 2.15 (95% CI: 1.33-3.50) per 1000 person/years. CONCLUSION: This study suggests that there may be geographical differences in the association between pSS and breast cancer risk; patients with pSS in European countries are associated with a lower risk of breast cancer, while Asia and Argentina are the opposite. Future research is needed to further characterize the effect of pSS on breast cancer risk and the pathophysiological mechanisms underlying this association to unravel the complex relationship between the two. |
format | Online Article Text |
id | pubmed-9283727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92837272022-07-16 Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis Deng, Jian Liu, Mengsi Xiao, Ruoyi Wang, Jin Liao, Xibei Ye, Zhen Sun, Zhen Front Immunol Immunology BACKGROUND: Primary Sjögren’s syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to investigate the risk, incidence, and mortality of breast cancer in patients with pSS. METHODS: We systematically searched Embase, PubMed, and Web of Science on January 31, 2022 to identify the study that assessed risk, incidence, or mortality of breast cancer in pSS. The fixed or random-effects models were applied to pool the effect estimates based on heterogeneity measured by Cochran’s Q-test and Higgins’ I(2). RESULTS: Ten studies involving 725,805 participants and 64,836 pSS patients were included in our analysis. The pooled result showed that, overall, pSS was not associated with the risk (SIR=0.92, 95%CI: 0.66-1.29, P=0.646) and mortality (HR = 0.78, 95%CI: 0.26-2.34, P = 0.664) of breast cancer; however, when stratified by geographic region, we found that patients with pSS in Asian countries (SIR=1.32, 95%CI: 1.10-1.58, P=0.003) and Argentina (SIR=3.76, 95%CI: 1.04-9.45, P=0.019) had an elevated risk of breast cancer, while pSS in Europe was associated with a reduced risk (SIR=0.61, 95%CI: 0.51-0.73, P<0.001). The pooled result from 28,635 female pSS patients indicated that the incidence of breast cancer was 2.15 (95% CI: 1.33-3.50) per 1000 person/years. CONCLUSION: This study suggests that there may be geographical differences in the association between pSS and breast cancer risk; patients with pSS in European countries are associated with a lower risk of breast cancer, while Asia and Argentina are the opposite. Future research is needed to further characterize the effect of pSS on breast cancer risk and the pathophysiological mechanisms underlying this association to unravel the complex relationship between the two. Frontiers Media S.A. 2022-07-01 /pmc/articles/PMC9283727/ /pubmed/35844507 http://dx.doi.org/10.3389/fimmu.2022.904682 Text en Copyright © 2022 Deng, Liu, Xiao, Wang, Liao, Ye and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Deng, Jian Liu, Mengsi Xiao, Ruoyi Wang, Jin Liao, Xibei Ye, Zhen Sun, Zhen Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title | Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title_full | Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title_fullStr | Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title_short | Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis |
title_sort | risk, incidence, and mortality of breast cancer in primary sjögren’s syndrome: a systematic review and meta-analysis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283727/ https://www.ncbi.nlm.nih.gov/pubmed/35844507 http://dx.doi.org/10.3389/fimmu.2022.904682 |
work_keys_str_mv | AT dengjian riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT liumengsi riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT xiaoruoyi riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT wangjin riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT liaoxibei riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT yezhen riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis AT sunzhen riskincidenceandmortalityofbreastcancerinprimarysjogrenssyndromeasystematicreviewandmetaanalysis |